Recently, a genomic study on anti-MDA5 antibody-positive dermatomyositis completed through collaboration between the Department of Rheumatology at PUMCH (led by Director Li Mengtao and Deputy Director Wang Qian) and the Second Affiliated Hospital of Nanchang U...

Cysteinyl leukotriene receptor 2 (CysLT2R) has recently become a "rising star" in drug development due to its unique tissue distribution and physiological functions. Recently, a collaborative team led by Zhang Shuyang, President of PUMCH, and Luan Xiao...

Recently, Deputy Director Dr. Zhao Haitao and Associate Chief Physician Dr. Yang Xiaobo's team from the Department of Liver Surgery, PUMCH published significant research findings in the prestigious journal Liver Cancer (a tier 1 journal, ranked among the top 5...

A collaborative research team led by Zhang Shuyang, President of PUMCH, and Luan Xiaodong, Director of the Drug Development and Evaluation Platform under PUMCH, together with researcher Chen Houzao from the Institute of Basic Medical Sciences, Chinese Academy ...